Pfizer, member of Bio Nebraska, and BioNTech announced today that their vaccine candidates received Fast Track designation from the U.S. Food and Drug Administration. Read more
Julie Anderson of the Omaha World-Herald reports that UNMC and Nebraska Medicine have partnered with over 350 other medical centers to improve patient outcomes. Read more
Bio Nebraska member ADS Biotec announces availability of COVID-19 Antibody kits that detect coronavirus antibodies in human blood samples. Read more
Omaha World-Herald staff writer Erin Duffy covers Bio Nebraska member, BD, and their expansion’s role in the fight against COVID-19. Read more
Bio Nebraska member, Amgen, talks to Fortune about testing drugs and beginning clinical trials to treat symptoms of COVID-19. Read more
LI-COR Biosciences, Bio Nebraska member, continues to support virology researchers with products, tools, and services to better understand COVID-19. Read more
We are excited to welcome Staska Pharmaceuticals as a new Bio Nebraska member! Read more
Bio Nebraska member, Pfizer, and BioNTech announced preliminary data from the most advanced of four investigational vaccine candidates from their BNT162 mRNA-based vaccine program. Read more
